VOYAGER
LIVE

Serial Number

90555777

Owner

Voyager Therapeutics, Inc.

Attorney

Keith Toms, Esq.

Filing Date

Mar 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VOYAGER Trademark

Serial Number: 90555777 • Registration: 7295072

VOYAGER is a trademark filed by Voyager Therapeutics, Inc. on March 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Voyager Therapeutics, Inc. (18 trademarks)

75 Hayden Avenue
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

March 2, 2021

Registration Date

January 30, 2024

Published for Opposition

May 3, 2022

Goods & Services

Biological preparations for gene therapy, namely, the treatment of Huntington's disease, Gaucher Disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, neurodegenerative disease, and Parkinson's disease; Biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, Huntington's disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, neurodegenerative disease, and Parkinson's disease; treatments for neurological diseases via gene replacement or gene knockdown, namely, the treatment of Huntington's disease, Gaucher Disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, neurodegenerative disease, and Parkinson's disease

Pharmaceutical research and development in the field of gene therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; Providing medical and scientific research information in the field of clinical trials and gene therapy; Providing a website featuring information about medical research

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 22, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 28, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 27, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 27, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 27, 2023 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 9, 2023 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Nov 8, 2023 SUPC
SOU EXTENSION 3 GRANTED
Nov 8, 2023 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 8, 2023 AITU
SOU EXTENSION 3 FILED
Nov 3, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 3, 2023 EEXT
USE AMENDMENT FILED
Nov 2, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 2, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jun 22, 2023 EX2G
SOU EXTENSION 2 FILED
Jun 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 30, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 28, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 28, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 28, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 30, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 30, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 30, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 30, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 23, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 2, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2021 NWOS
NEW APPLICATION ENTERED
Mar 5, 2021 NWAP